Hypothesis / aims of study
Bladder bowel dysfunction (BBD) is a combination of bladder and bowel disturbances in children who have no identifiable or recognizable neurologic abnormality. In BBD the entire pelvic floor is dysfunctional, bladder and bowel are just a part of it.
We here in describe that the muscular component (bulbospongiosus muscle [BSM]) of the pelvic floor may substantially contribute to the voiding disorder children.
Study design, materials and methods
Study includes all children presented to us with lower urinary tract (LUTS) and bowel symptoms (constipation / incontinence). After ruling out of any other causes of symptoms like neurogenic or structural abnormality, bladder and bowel diaries with uroflowmetry and pelvic floor EMGs (Fig. 1) were assessed. The children who continued to have persistent LUTS even after 3 months of Urotherapy were further subjected to pelvic floor functional MRI (FrMRI) (Fig. 2) and high-resolution anorectal manometry (HRAM) to study the anatomy and physiology of pelvic floor muscular components with special reference to bulbospongiosus muscle.
Dysfunctional voiding score system (DVSS) was obtained at start of the treatment which was also used for the monitoring of symptoms.
Management included Urotherapy along with EMG biofeedback and bowel program.
Interpretation of results
The Fr MRI during voiding showed occlusive contraction of bulbospongiosus in children with BBD (Fig. 2). HRAM also recorded high anal pressure while attempting for evacuation (Fig. 3). The authors hypothesize that the muscular component (bulbospongiosus muscle [BSM]) of the pelvic floor may substantially contribute to the voiding disorder children.
Targeted Urotheray showed good response in 4 (33.3%) children and rest 8 (67.7%) needed more aggressive second line of management (Botulinum toxin, Neuromodulation and Pharmacotherapy).